COSA's 45th Annual Scientific Meeting, 13 - 15 November 2018 Perth Convention and Exhibition Centre

Dr Dirk Arnold

Dr Dirk Arnold is a professor of oncology of the University of Hamburg, Germany. Currently, he is the Medical Director of the Instituto CUF de Oncologia in Lisbon, Portugal.

He received his medical training and qualified as MD and PhD at Charité University Hospital of Berlin, Germany, and at the Martin Luther University of Halle-Wittenberg, Germany. From 2010–2012 he was medical director of the Hubertus Wald Tumor Center at University Cancer Center Hamburg, Germany, and from 2013–2015 he served as director of the Klinik für Tumorbiologie, Freiburg, Germany.

Dr Arnold’s research interests focus on clinical and translational cancer research in the development of modern treatment strategies for GI cancers with the integration of novel drugs, and optimizing treatment structures for patients with malignancies in large-scale networks for research and cancer care.

He is one of the current editors for GI cancers for the Guidelines Working Group of ESMO, where he also serves as member of the executive board. He is a co-chairman of the Colorectal Cancer Study Group of the Arbeitsgemeinschaft Internistische Onkologie (AIO), and serves as member of the EORTC’s Colorectal Cancer Task Force. He is a member of the American Society of Clinical Oncology, German Cancer Society (Deutsche Krebsgesellschaft), German Association of Hematology and Oncology (Deutsche Gesellschaft für Hamatologie und Medizinische Onkologie).

Dr Arnold has published more than 170 peer-reviewed scientific papers and articles, mainly on colon cancer, gastroesophageal cancer, radiochemotherapy, and rectal cancer, and multimodal and innovative treatment strategies. Dr Arnold has served as the (co-)principal investigator of numerous clinical, mainly in the setting of multidisciplinary and cooperative group landscape. Furthermore, his interests are aspects of value assessment in oncology, as well as structural environments as in cancer centres and research networks.

Sponsored by Merck logo